Showing results (2521-2530 of 2,949) with videos related to

Sort By:
Pageof 295
Oncogene|July 31, 1997
Characterization of murine Flt4 ligand/VEGF-CL J Fitz, J C Morris, P Towler, et al.
Science Translational Medicine|July 1, 2011
Human apoE isoforms differentially regulate brain amyloid-β peptide clearanceJoseph M Castellano, Jungsu Kim, Floy R Stewart, et al.
Journal for Immunotherapy of Cancer|September 10, 2020
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor studyClaire F Verschraegen, Guy Jerusalem, Edward F McClay, et al.
Hemasphere|September 15, 2021
The EHA Research Roadmap: Immune-based Therapies for Hematological MalignanciesHermann Einsele, Javier Briones, Fabio Ciceri, et al.
Journal of Alzheimer'S Disease : JAD|July 18, 2025
Baseline and longitudinal changes in cortical thickness and hippocampal volume predict cognitive declineGengsheng Chen, Nicole S McKay, Brian A Gordon, et al.
The Lancet. Neurology|March 21, 2026
Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease: a prospective cohort studyNiklas Mattsson-Carlgren, Sebastian Palmqvist, Kanta Horie, et al.
Biomed Research International|April 30, 2015
Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease: Results of the DIAN StudyChristoph Laske, Hamid R Sohrabi, Mateusz S Jasielec, et al.
Cerebral Cortex (New York, N.Y. : 1991)|July 18, 2008
The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individualsBradford C Dickerson, Akram Bakkour, David H Salat, et al.
Neurology|May 18, 2023
Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Life SpanJingqin Luo, Yinjiao Ma, Folasade Jane Agboola, et al.
Bone Marrow Transplantation|May 28, 2013
Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow TransplantationH W Auner, R Szydlo, A van Biezen, et al.
Pageof 295